Identification of microRNAs involved in gefitinib resistance of non-small-cell lung cancer through the insulin-like growth factor receptor 1 signaling pathway

Multiple clinical and experimental studies have suggested that epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) may be effective at treating advanced non-small cell lung cancer (NSCLC), however, the molecular basis of primary resistance to EGFR-TKIs in NSCLC remains unclear. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Wei, Kang, Yanhong, Ning, Lanlan, Tan, Jie, Wang, Hanping, Ying, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585727/
https://www.ncbi.nlm.nih.gov/pubmed/28912847
http://dx.doi.org/10.3892/etm.2017.4847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585727/
https://www.ncbi.nlm.nih.gov/pubmed/28912847
http://dx.doi.org/10.3892/etm.2017.4847

Ejemplares similares